Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα
Science Immunology · 17.10.2025 · 10 (112)
DOI: 10.1126/sciimmunol.adv5085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 17.10.2025. Verfasst von Zhenghai Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montréal, Canada. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Immunologic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Signal regulatory protein α (SIRPα) is a macrophage inhibitory receptor that limits phagocytosis and antitumor activity by interacting in trans with CD47 on tumor cells. Here, we found that a component of SIRPα’s inhibitory function occurred independently of CD47. Inhibition occurred because of interactions between SIRPα and CD18 (β 2 integrin) in cis on the surface of macrophages, involving SIRPα amino acids distinct from those implicated in the SIRPα-CD47 interaction. This cis interaction prevented activation of CD18, which is necessary for phagocytosis. The combined blockade of SIRPα-CD18 and SIRPα-CD47 was essential for maximizing phagocytosis and suppression of tumor growth in vivo. Thus, inhibitory immune checkpoints such as SIRPα suppress cell activation through a mechanism targeting CD18 in cis, which occurs in addition to engagement by their inhibitory checkpoint ligands in trans. This dual mode of action should be considered when developing inhibitory checkpoint blockades for immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montréal, Canada.
- Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China.
- MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China.
- Department of Medicine, McGill University, Montréal, Canada.
- Department of Medicine, University of Montréal, Montréal, Canada.
ORCID-Profile: Zhenghai Tang, Ming-Chao Zhong, Jin Qian, Lok San Wong, Jiaxin Li, Cristian Camilo Galindo, Dominique Davidson, André Veillette
Zitieren
APA
Tang, Z., Zhong, M. C., Qian, J., Dou, J., Wong, L. S., Li, J., Galindo, C. C., Davidson, D., & Veillette, A. (2025). Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα. Science Immunology, 10(112). https://doi.org/10.1126/sciimmunol.adv5085
Vancouver
Tang Z, Zhong MC, Qian J, Dou J, Wong LS, Li J, et al. Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα. Science Immunology. 2025;10(112). doi:10.1126/sciimmunol.adv5085
BibTeX
@article{Tang2025,
author = {Tang, Zhenghai and Zhong, Ming-Chao and Qian, Jin and Dou, Jiayu and Wong, Lok San and Li, Jiaxin and Galindo, Cristian Camilo and Davidson, Dominique and Veillette, André},
title = {Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {112},
doi = {10.1126/sciimmunol.adv5085}
}
EUVIMED